KWS Biotest

charles river has recently acquired kws biotest. charles river is a leading global contract research organisation that helps clients accelerate their research and drug discovery efforts. kws biotest is an established contract research organization providing a wide range of drug discovery services spanning preclinical development from early cell biology, through efficacy models to clinical sample analysis. kws biotest provides clients with a powerful combination of world-leading scientific expertise coupled with the latest methods and technologies to ensure the highest levels of quality and service at all times. we specialise in the areas of immunology, inflammation and infection and work closely with our clients in the testing of their novel small molecules, biologics and adcs as treatments for human disease, including specific experience across global vaccine development initiatives. we can generate data to support all stages of compound and molecule development to maximise the chance